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Abstract
Following a request from the European Commission, the EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of Levucell® SC for dairy cows, cattle for fattening, all minor ruminant species and camelids.
The additive consists of viable cells of a strain of Saccharomyces cerevisae and is sold in three
formulations. The FEEDAP Panel considers that the three available formulations are equivalent when
used to deliver the same dose. The active agent fulﬁls the requirements of the qualiﬁed presumption
of safety approach to the assessment of safety and since no concerns are expected from other
components, Levucell® SC can be presumed safe for target animals, consumers of products from
treated animals and the environment. Levucell® SC is not a skin irritant or sensitiser but is an eye
irritant. Inhalation exposure is unlikely. Encapsulation is not expected to introduce hazards for users.
The FEEDAP Panel is not in the position to conclude on the efﬁcacy of Levucell® SC for dairy cows,
minor dairy ruminant species or dairy camelids. Levucell® SC has a potential to improve the
performance of cattle raised for fattening when supplied at a minimum dose of 8 9 109 CFU/head and
day which would approximate to 6 9 108 CFU/kg complete feed. This conclusion is extended to minor
ruminant species and camelids reared for meat production at the same minimum dose of
6 9 108 CFU/kg complete feed.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 10(2) of that Regulation also speciﬁes that for
existing products within the meaning of Article 10(1), an application shall be submitted in accordance
with Article 7, at the latest one year before the expiry date of the authorisation given pursuant to
Directive 70/524/EEC for additives with a limited authorisation period, and within a maximum of seven
years after the entry into force of this Regulation for additives authorised without a time limit or
pursuant to Directive 82/471/EEC. In addition, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from LALLEMAND SAS2 for re-evaluation and
authorisation of the product Levucell® SC (Saccharomyces cerevisiae CNCM I-1077), when used as a
feed additive for dairy cows and cattle for fattening (category: zootechnical additive; functional group:
digestibility enhancer) and for calves, buffaloes and all ruminants species for fattening (category:
zootechnical additive; functional groups: digestibility enhancer and gut ﬂora stabiliser). During the
assessment the applicant introduced several amendments to the original mandates: (i) added the
functional group gut ﬂora stabiliser in the mandate for dairy cows and cattle for fattening, (ii)
withdrew the request for authorisation for calves, and (iii) clariﬁed the request for authorisation for
minor species which include animals for fattening and for milk production as well as all camelids (i.e.,
all the camelid species of the family Camelidae).3
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application
to the European Food Safety Authority (EFSA) as an application under Article 10(2) (re-evaluation of an
authorised feed additive) and as an application under Article 4(1) (authorisation of a feed additive or new
use of a feed additive). EFSA received directly from the applicant the technical dossiers in support of
these applications. The particulars and documents in support of the applications were considered valid by
EFSA as of 9 October 2014 and 23 June 2014, respectively.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of Levucell®
SC (Saccharomyces cerevisiae CNCM I-1077), when used under the proposed conditions of use (see
Section 3.1.4).
1.2. Additional information
The additive is a preparation of Saccharomyces cerevisiae (CNCM I-1077). The Scientiﬁc Committee
on Animal Nutrition (SCAN) issued an opinion on the safety of this product for beef and dairy cattle,
including safety for the user, the consumer and the environment (European Commission, 1997,
updated 2003). The FEEDAP Panel has issued several opinions on the safety and efﬁcacy of this
product, one for dairy goats and dairy ewes (EFSA, 2006a), two for leisure horses (EFSA, 2006b,
2009) and one for lambs (EFSA, 2008a).
The additive is currently authorised for use in dairy cows and cattle for fattening,4 dairy goats and
dairy ewes,5 lambs6 and horses.7
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Lallemand SAS, 19, Rue des Briquetiers BP 59, 31702 Blagnac, France.
3 Technical dossier/Supplementary information March 2017/Annexes 1a and 1b.
4 Commission Regulation (EC) No 1200/2005 of 26 July 2005 concerning the permanent authorisation of certain additives in
feedingstuffs and the provisional authorisation of a new use of an additive already authorised in feedingstuffs plus
amendments. OJ L 195, 27.7.2005, p. 6–10.
5 Commission Regulation (EC) No 226/2007 of 1 March 2007 concerning the authorisation of Saccharomyces cerevisiae CNCM
I-1077 (Levucell SC20 and Levucell SC10 ME) as a feed additive. OJ L 64, 02.03.2007, p. 26–28.
6 Commission Regulation (EC) No 1293/2008 of 18 December 2008 concerning the authorisation of a new use of Saccharomyces
cerevisiae CNCM I-1077 (Levucell SC20 and Levucell SC10 ME) as a feed additive. OJ L 340, 19.12.2008, p. 38.
7 Commission Regulation (EC) No 910/2009 of 29 September 2009 concerning the authorisation of a new use of the preparation
of Saccharomyces cerevisiae CNCM I-1077 as a feed additive for horses (holder of authorisation Lallemand SAS). OJ L 275,
30.9.2009, p. 7.
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The species S. cerevisiae is considered by EFSA to be suitable for the Qualiﬁed Presumption of
Safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2017). This approach
requires the identity of the strain to be conclusively established.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of two technical
dossiers8 in support to the authorisation request for the use of Levucell® SC (Saccharomyces
cerevisiae CNCM I-1077) as a feed additive. The technical dossier was prepared following the
provisions of Article 7 of Regulation (EC) No 1831/2003 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agent in animal feed. The Executive Summary of the EURL
report can be found in Annex A.9
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Levucell® SC
is in line with the principles laid down in Regulation (EC) No 429/200810 and the relevant guidance
documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Guidance on studies
concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012b), Technical
Guidance: Extrapolation of data from major species to minor species regarding the assessment of
additives for use in animal nutrition (EFSA, 2008b).
3. Assessment
The additive is a preparation consisting of viable dried cells of S. cerevisiae (CNCM I-1077) intended
for use as a zootechnical additive (digestibility enhancer and gut ﬂora stabiliser) in feed for dairy cows,
cattle for fattening and all minor ruminant species and camelids to improve zootechnical performance.
3.1. Characterisation
3.1.1. Characterisation of the active agent
The S. cerevisiae strain was originally isolated from grape must and is deposited at Collection
Nationale de Cultures de Microorganismes (CNCM, France) with the accession number CNCM I-1077.11
It has not been genetically modiﬁed.
Species identiﬁcation was established based on the carbohydrate fermentation patterns and by
partial sequencing of the 28S rRNA gene (domain D1/D2, about 500 base pairs).12 Strain level
identiﬁcation is based on d-polymerase chain reaction (PCR) and microsatellites PCR for 13 loci.13
Genetic stability was shown by PCR ﬁngerprinting and conﬁrmed by comparison of the d-PCR proﬁles
of eight samples obtained from different batches of the product.14
3.1.2. Manufacturing process and properties of the additive15
The manufacturing process of the additive is detailed in the dossier. The additive is available in
three forms:
8 FEED dossier references: FAD-2010-0120 and FAD-2013-0054.
9 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep-fad-2010-0120-levucell.pdf
10 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
11 Technical dossiers/Section II/Annex II.2.1.
12 Technical dossier/Section II and Supplementary information October 2016/Annex 1a.
13 Technical dossier/Supplementary information October 2016/Annex 1b.
14 Technical dossiers/Section II/Annex II.2.3.
15 This section has been edited following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
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• Levucell® SC20, a ﬁne, granulated free-ﬂowing powder with a minimal concentration of viable
yeast cells of 2 9 1010 colony forming units (CFU)/g of additive (granulated form),
• Levucell® SC10 ME and Levucell® SC Titan16 (coated or microencapsulated forms), with a
minimal concentration of viable yeast cells of 1 9 1010 CFU/g of additive. These two
formulations differ in appearance due to a difference in the drying process (including fatty
acids).17 For practical purposes, the two forms can be considered equivalent.18
The dossiers include data conﬁrming compliance with the minimum speciﬁcations of the additive.19
Each production batch is tested for microbiological purity and the threshold levels set as follows: total
aerobic bacteria < 107 CFU/g, coliforms < 10 CFU/g, Escherichia coli < 10 CFU/g, wild yeasts < 105 CFU/g
and the absence of Salmonella in 25 g. Analyses of three batches (of a non-speciﬁed form) were provided
and found to be in compliance with these action limits regarding total aerobic bacteria, coliforms and
Salmonella. No data on the presence of wild yeasts or E. coli were provided.20 In addition, the counts of
staphylococci, anaerobic sulfate-reducing bacteria and Clostridium perfringens were determined and
found to be below the detection levels (pathogenic staphylococci < 100 CFU/g, anaerobic sulfate-reducing
bacteria < 10 CFU/g and C. perfringens < 10 CFU/g).
Action limits are set for heavy metals (cadmium < 0.5 mg/kg, mercury < 0.1 mg/kg and lead
< 5 mg/kg), arsenic (< 2 mg/kg) and mycotoxins (aﬂatoxins B1, B2, G1, G2 and ochratoxin A
≤ 0.005 mg/kg, zearaleone ≤ 0.1 mg/kg). Three batches of the coated form were tested for heavy
metals and arsenic and three of the granulated form and three of a not speciﬁed form were tested for
mycotoxins and found all to be complying with speciﬁcations.21 Additional three batches of SC20 and
three of SC Titan were tested for mycotoxins and found to be compliant with actions limits.22 Dioxins
and furans contamination was also determined for the granulated and for microencapsulated products
in three batches each.23 Values for total TEQ (sum of the total dioxins and total furans) were
≤ 0.061 ng/kg and ≤ 0.075 ng/kg for the SC20 and SC10 ME forms, respectively.
The particle size distribution tested by mechanical sieving in four batches of the SC20 formulation
proved that this form has less than 0.03% (w/w) particles with a diameter < 100 lm.24 Analyses using
optical sieving were performed with three batches of the SC20 form, seven batches of the SC10 ME
form, and six of the SC Titan form.25 In the ﬁrst case, approximately 0.3% (v/v) of particles had
diameter < 90 lm and 0.1% (v/v) of particles < 45 lm. In the second case, the mean particle size
was approximately 660 lm while the smallest particles had a diameter of 140 lm. In the third case,
the mean particle size was approximately 993 lm and no particles had a diameter below 50 lm. The
dusting potential of two batches of the SC20 form tested using the Stauber–Heubach dustometer gave
a mean value of 23 mg/m3.26
3.1.3. Stability and homogeneity
Shelf life of Levucell® SC10 ME (two batches) was assessed at three storage temperatures (40°C,
30°C and 20°C) and compared against one batch of the non-coated form, Levucell® SC20.27 These
were packed under nitrogen in bags made of the same material as the commercial packaging. Both
forms were stable throughout the whole test periods (3 months at 40°C, for 4 months at 30°C and
12 months at 20°C).
Stability at 20°C for 24 months was tested with three batches of the SC20 form contained in sealed
(under vacuum) packaging and with ﬁve batches in packaging materials in the presence of air. No
losses of viability were observed when the additive was stored under vacuum. In the presence of air,
minimal losses of viability were seen (decline from 3 9 1010 to 2 9 1010 CFU/g).26 When stored at
5°C, two batches stored under vacuum and four batches stored under residual air showed minimal
losses of viability (decline from 3 9 1010 to 2 9 1010 CFU/g).
16 This is apparently also marketed with the tradename Levucell® SC10 ME Titan.
17 Technical dossiers/Section II/Annex II.1.4a.
18 Technical dossiers/Section II/Annexes II.3.3 and II.3.4.
19 Technical dossier/Section II/Annexes II.3.3 and II.3.4.
20 Technical dossiers/Section II/Annex II_1_3.
21 Technical dossiers/Section II and Supplementary information October 2016/Annex II_1_3.
22 Technical dossiers/Supplementary information October 2016/Annexes 2b and 2c.
23 Technical dossier/Section II/Annex II_1_4.
24 Technical dossiers/Section II/Annex II_1_5.
25 Technical dossiers/Section II/Annexes II_1_6a and 6b and Supplementary information October 2016/Annexes 3c, 3d and 3e.
26 Technical dossiers/Section II/Annex II_4_15 and Supplementary information October 2016/Annex 3a.
27 Technical dossiers/Section II/Annex II_4_1.
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Three batches of SC Titan in the original packaging were stored at 5 and 25°C (60% relative
humidity (RH)) for 36 months. All batches were either stable or showed minimal losses of viability,
remaining above the speciﬁcations over this period.28
Two batches of SC10 ME and one of SC20 were packed under nitrogen and stored at 40°C for
3 months, at 30°C for 4 months and at 20°C for 12 months.29 All batches were either stable or
showed minimal losses of viability, remaining above the speciﬁcations over this period.
Further studies were done with one batch of SC20 when exposed to light at different intensities, or
stored at different temperatures (4°C, 20°C, 40°C and 65°C) or moisture (RH 20%, 50%, 70–80% and
at ambient room conditions) for 1 month. The product was stable at different moisture conditions, but
did not tolerate storage at 65°C (complete loss of viability occurred within 24 h).30
Stability of nine batches of SC20 and three and six of the coated forms was tested when mixed
with a vitamin/mineral premixture for ovines, a mineral premixture for bovines and a mineral
premixture for bovines and goats (none containing choline chloride).31 The additive was incorporated
at 0.3–1% and the samples were stored in aluminium bags at 20°C for 6 months (expected levels
1010–1011 CFU/kg). The viability loss during this time was small (< 0.5 log) in all cases.
Stability of three batches of SC20 was tested when mixed with a mash feed for ruminants
(expected concentration of 1 x 109 CFU/kg), contained in aluminium bags and stored at 20°C for
3 months.30 The viability loss during this time was negligible. In the same study, three batches of the
SC10 ME and three batches of the SC Titan forms were mixed with a feed for dairy ruminants
(expected concentration of 5 9 109 – 1 9 1010 CFU/kg), subject to pelleting (at 50–65°C), packed in
aluminium bags and stored at 20°C for 3 months.30 Yeast counts were measured before and after
pelleting to allow testing for survival during processing. No losses were observed in any of the counts
after pelleting and after the 3 months of storage, denoting stability of both forms to pelleting and
storage. In an additional study, stability of six batches of SC Titan to different pelleting conditions was
tested.32 In this case, the additive was incorporated in a cow feed (at 1 g/kg) and the mixture was
subject to pelleting at 70, 75 and 80°C. Differences in viable counts measured before and after
pelleting at 70 and 75°C were in all batches < 0.5 log, denoting good stability to pelleting up to 75°C.
Viability losses at 80 °C were slightly over 0.5 log values.
The capacity of one batch of SC20 and SC10 ME, and two of the SC Titan form to homogeneously
mix with mash and pelleted feed for dairy and fattening ruminants was tested in another study.33 The
additive was added to the feed to deliver the yeast at 108–109 CFU/kg in the feed for dairy ruminants
and at 1 9 1010–11 CFU/kg in the feed for fattening bovines. Yeasts analyses of 10 subsamples showed
coefﬁcients of variation < 2% in all cases, denoting capacity to homogeneously mix.
3.1.4. Conditions of use
The additive is intended for use in complete feed for dairy cows and minor ruminant species for
milk production at the minimum dose of 4 9 108 CFU/kg, for cattle for fattening and minor ruminant
species for fattening at the minimum dose of 5 9 108 CFU/kg and for all camelids at the minimum
dose of 4 9 108 CFU/kg.
3.2. Safety
3.2.1. Safety for the target species, consumer and environment
In the view of the FEEDAP Panel, the identity of the strain has been established as S. cerevisiae
(CNCM I-1077). According to the QPS approach to safety assessment, it can be presumed safe for
target animals, consumers of products derived from animals fed the additive and the environment. No
concerns are expected from other components of the additive. Consequently, Levucell® SC can be
presumed safe for target animals, consumers of products derived from animals fed the additive and
the environment.
28 Technical dossier FAD-2013-0054/Section II/Annex II_4_2b.
29 Technical dossiers/Section II/Annex II_4_2.
30 Technical dossiers/Section II/Annex II_4_3.
31 Technical dossiers/Supplementary information October 2016/Annex 4a.
32 Technical dossiers/Supplementary information October 2016/Annex 4b.
33 Technical dossiers/Supplementary information October 2016/Annex 4c.
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3.2.2. Safety for the user
No speciﬁc studies on inhalation toxicity were submitted. Although the active agent, owing to its
proteinaceous nature, is considered to be a potential respiratory sensitiser, none of the formulations
contains particles of respirable size. Thus, the exposure of users is unlikely. In addition, the dusting
potential of the SC20 form, which is expected to be the dustiest form, is low.
Studies with ﬁve New Zealand White rabbits were made to investigate possible irritancy potential of
Levucell® SC20 to skin34 and eyes35 following OECD guidelines 404 and 405, respectively. No skin
irritation or oedema was observed after 24 and 72 h of a single application of the test material. Thus,
the additive is considered non-irritant to skin. There was evidence of eye irritation with the additive,
including redness, watering and chemosis at the conjunctival level in all animals. These effects lasted
for 72 h. At 96 h, three of the animals showed a light redness which was not visible at 120 h. Thus,
Levucell® SC20 is an eye irritant.
In an experiment compliant with OECD Guideline 429, the skin sensitisation potential of Levucell®
SC20 was tested.36 The test material was considered to be non-sensitiser under the test conditions.
In all of the studies described, the test item was the non-coated form. Encapsulation is not
expected to introduce other hazards for users.
3.2.2.1. Conclusions on safety for the user
Levucell® SC20 is not a skin irritant or sensitiser but is an eye irritant. Inhalation exposure is
unlikely. Encapsulation is not expected to introduce other hazards for users.
3.3. Efﬁcacy
3.3.1. Efﬁcacy for dairy cows
Eight studies performed in ﬁve different Member States were submitted to show the effects of
Levucell on the performance of dairy cows. Three37 studies could not be further considered due to
ﬂaws in the experimental design, as feed intake and ingestion of the additive were not determined in
each cow. In addition, in one of these studies,38 a poor quality silage was given during 2 weeks and
caused an unacceptable reduction in feed intake and milk production.
The remaining ﬁve trials followed a similar design, which is described in Table 1. Although different
forms of the additive were used in the studies, the FEEDAP Panel considers that the results of efﬁcacy
studies can be applied to any of the three available formulations when used to deliver the same dose.
In all cases the intended dose is expressed in CFU/cow per day (1 9 1010 CFU/cow per day). Based
on the analysed concentrations in the batch of additive used and in the premixture to which the
additive was incorporated and the feed intake in each case, the equivalent dietary concentration in
CFU/kg feed was calculated.
34 Technical dossiers/Section III/Annex_III_3_1.
35 Technical dossiers/Section III/Annex_III_3_2.
36 Technical dossiers/Supplementary information October 2016/Annex 5.
37 Technical dossier FAD-2010-0120/Section IV/Annexes IV_1_1, IV_1_2 and IV_1_5.
38 Technical dossier FAD-2010-0120/Section IV/Annex IV_1_5.
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In study 1, 44 Holstein cows (1/3 primiparous and 2/3 multiparous) were randomly divided into a
control group and a group receiving Levucell® SC administered through concentrate in order to supply
1 9 1010 yeast cells/cow daily. Before the allocation to the groups, cows were paired according to
calving date, lactation number, and previous lactation yield.39 The study started when cows were on
average at day 43 of lactation and lasted for 84 days. From the microbiological analysis of the
concentrate (1.6 9 109 CFU/kg concentrate), it was calculated that treated cows received the additive
at 6 9 108 CFU/kg complete feed. Cows were individually housed in cubicles with a central feeder
where a forage based diet was provided ad libitum. Group forage intake was determined monthly.
Cows were given a concentrate according to their milk yield up to a maximum daily amount of
10.5 kg/cow. Pelleted concentrate was available at computerised out-milking parlour individual feeders,
and 1 kg of concentrate (containing the additive) was fed during milking. Daily concentrate intake was
on average 5.9 and 6.5 kg/cow in the control and Levucell® SC groups, respectively. Milk yield was
recorded daily for each cow, and then records of four consecutive days were averaged. Milk
composition was determined every 4 weeks. Individual body condition score (BCS, 5-point scale) was
assessed every 5 weeks. Milk yield data with the cow as experimental unit were analysed using a
linear mixed model with the dietary treatment and parity as ﬁxed factors, with milk recordings within
each cow during the study as repeated measurements in time. Means of body condition score were
compared using a Student t-test. Differences were considered as signiﬁcant for p < 0.05.
In the second trial, 36 Red Holstein Friesian 9 Simmental cows were randomly distributed in two
homogeneous groups (of 1 primiparous and 17 multiparous each) according to their performance in the
previous lactation (milk yield and composition), body weight, BCS and the time of calving.40 The
Table 1: Details on the study design for the studies with dairy cows
Trial Breed
Total animals
(cows/
treatment)
Levucell® SC in
supplemented group
(CFU/cow per day)
Duration of
the study
(days)
Diets – main ingredients
(percentage of forage and
concentrate in the daily
ration)
1 Holstein 44
(22)
1 g Levucell® SC10 ME
(1 9 1010)
104 Basal forage diet (grass and
corn silage) supplemented
with pelleted concentrate
(60% forage, 40%
concentrate)
2 Red Holstein
Friesian
9 Simmental
36
(18)
0.5 g Levucell® SC20
(1 9 1010)
84 Partial mixed ration (maize
silage, lucerne hay and protein
concentrate) supplemented
with concentrate
(60% forage, 40%
concentrate)
3 Polish
Holstein-
Friesian
24
(12)
1 g Levucell® SC10 ME
(1 9 1010)
84 Maize silage, lucerne silage,
rapeseed meal, beet pulp
(60% forage, 40%
concentrate)
4 Prim’Holstein 38
(19)
1 g Levucell® SC Titan
(1 9 1010)
90 Partial mixed ration (maize
silage, lucerne hay and protein
concentrate) supplemented
with concentrate
(78% forage, 22%
concentrate)
5 Polish
Holstein-
Friesian
22
(11)
1 g Levucell® SC Titan
(1 9 1010)
98 Maize silage, lucerne silage,
high moisture maize grain
silage, rapeseed meal, beet pulp
(52% forage, 48%
concentrate)
CFU: colony forming unit.
39 Technical dossier FAD-2010-0120/Section IV/Annex IV_1_3, Supplementary information October 2016/Annex 8 and
Supplementary information March 2017/Annexes 3.
40 Technical dossier FAD-2010-0120/Section IV/Annex IV_1_4.
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experiment lasted 12 weeks. The experiment started 3 weeks before calving and was extended until
12 weeks post-partum. Animals were housed in a loose stable equipped with individual feed troughs.
Cows had free access to a partially mixed ration in an outside feeding area, and those producing more
than 22 kg milk/day received up to 8 kg of additional concentrate, according to their performance. Cows
in the treated group received the additive mixed with 1.5 kg of the concentrate. The analysed yeast
concentration in the concentrate was 6.8 9 109 CFU/kg, corresponding to a calculated concentration of
4.8 9 108 CFU/kg complete feed. Those in the control group received only the concentrate without the
additive. Concentrate intake was measured daily for each cow. Milk yield was automatically recorded for
each cow and at each milking (twice a day). Live weight was recorded weekly, using scales installed at
the exit of the milking room. All parameters were analysed by analysis of variance (ANOVA) with
treatment and blocking effects included in the model with the cow as experimental unit. Means were
separated using the Student–Newman–Keuls test when F-values were signiﬁcant (p < 0.10).
In study 3, 24 Polish Holstein-Friesian multiparous (third parity) cows were blocked according to their
expected calving date, and then randomly assigned to one of two treatments (control and Levucell).41
All animals entered the experiment 2 weeks before calving and were monitored during 14 weeks. In the
treated group, Levucell® SC was provided in a mineral premixture that was added on top of the total
mixed ration (TMR) before mixing. Animals in the control group received the same amount of mineral
premixture. From the microbiological analysis of the premixture (5.2 9 1011 CFU/kg), it was calculated
that treated cows received the additive at 4 9 108 CFU/kg complete feed. During the experimental
period, cows from each group were kept in separate loose housing and were individually fed (Calan
Broadbend gates). The TMR was fed ad libitum, feed consumption was measured on a daily basis and
cows were milked three times. Feed intake data were computed on a weekly basis for statistical analysis.
Milk production was recorded daily on an individual basis. Milk composition was determined once per
month and per cow over the 12 weeks of production. Individual BCS (5-point scale) was assessed every
2 weeks. Data with the cow as experimental unit were analysed by ANOVA using a mixed model with
repeated measurements. Differences were considered as signiﬁcant for p < 0.05.
In the fourth study, 38 Prim’Holstein cows were randomly distributed in two groups.42 Primiparous
heifers and multiparous cows were evenly distributed in both groups. Cows were paired according to the
lactation number, number of days after calving, and milk production and composition at grouping. The
animals were housed in a loose barn with cubicles, and a partial mixed ration was freely available at the
feeding trough (one per experimental group). In addition, each cow received 1 kg of concentrate with
(cows of the Levucell® SC group) or without (control group) the additive, and another kg of concentrate
for every 2.5 kg of milk produced above a daily yield of 25 kg milk. Concentrates were distributed during
milking. The analysed yeast cell counts in the concentrate were 8.9 9 109 CFU/kg, from which the
calculated counting in complete feed was 2.8 9 108 CFU/kg. Individual concentrate consumption was
recorded daily. Partial mixed ration intakes were measured on a group basis, with an assessment of total
amount consumed monthly. Milk production was automatically recorded at each milking (average daily
number of milkings per cow was 2.5), and milk composition was determined in milk samples taken every
2 weeks. Body condition score was determined three times along the course of the study. Data with the
cow as experimental unit were subjected to ANOVA with repeated measurements. Number of days post-
partum and parity at grouping were used as covariates and removed from the model when non-
signiﬁcant. Average milk production of the ﬁrst month was used as covariate for the subsequent
13 weeks of milk production recordings.
The last study involved 22 Polish Holstein-Friesian cows blocked according to their parity, and then
randomly assigned to one of two treatments (control and Levucell).43 Cows entered the experiment
30 days after calving and were monitored during 14 weeks. In the treated group, Levucell® SC was
provided in a premixture (with corn meal as carrier) that was added on top of the TMR before mixing.
From the microbiological analysis of the premixture (2.6 9 1010 CFU/kg), it was calculated that treated
cows received the additive at 2.1 9 108 CFU/kg complete feed. During the experimental period, cows
from each group were kept in separate loose housing and were individually fed (Calan Broadbend
gates). The TMR was fed ad libitum, feed consumption was measured on a daily basis and cows were
milked three times per day on 8 h intervals. Milk production and feed intake were recorded daily for
each cow. Milk composition was determined biweekly and per cow. Individual BCS (5-point scale) was
41 Technical dossiers/Supplementary information October 2016/Annexes 6 and Supplementary information March 2017/Annexes
2a and 2b.
42 Technical dossiers/Supplementary information October 2016/Annexes 7.
43 Technical dossiers/Supplementary information March 2017/Annexes 2.
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assessed every 2 weeks. Data with the cow as experimental unit were subjected to ANOVA using a
mixed model with repeated measurements. Average milk production of the ﬁrst 2 weeks was used as a
covariate. Differences were considered as signiﬁcant for p < 0.05. A summary of the results of the
studies is presented in Table 2.
Although the results suggest that daily milk yield was signiﬁcantly increased (p < 0.10) in three
studies (1, 4 and 5), the Panel has reservations: the supply of concentrate (kg/kg milk) was based on
individual milk yield (in trials 1, 2 and 4) which makes it not possible to distinguish between response
to the additive or to the cumulative increases in the provision of concentrate.
The data on milk yield and feed intake of the ﬁve studies were tested for homogeneity and used in
a pooled analysis.44 However, the same reservations described above apply to this analysis.
In addition, the applicant made reference to a report published by de Ondarza et al. (2010) which
described a meta-analysis of 14 research trials involving the additive under assessment and conducted
in eight different countries (two of them non EU member states).45 However, the majority of the 14
studies considered would not meet the criteria of an efﬁcacy study, in particular in terms of duration.
Some of the data used are from studies reported only in the form of abstracts.
Therefore, the FEEDAP Panel is not in the position to conclude on the efﬁcacy of Levucell® SC for
dairy cows.
3.3.2. Efﬁcacy for minor ruminant species and camelids for milk production
An efﬁcacy study with dairy buffaloes was provided.46 However, this could not be further
considered due to ﬂaws in experimental design, as feed intake and ingestion of the additive were not
determined in each buffalo.
In the absence of demonstration of efﬁcacy in dairy cows, no extrapolation to minor dairy ruminant
species or dairy camelids can be made.
3.3.3. Efﬁcacy for cattle for fattening
Eight studies were submitted investigating the effects of supplementing Levucell® SC to cattle for
fattening on growth performance. Four of the studies could not be further considered due to ﬂaws in
the experimental design: two47,48 were of too short duration (< 168 days), another one49 lacked of
Table 2: Effect of Levucell ® SC on milk production and milk quality
Study
Levucell® SC
(CFU/kg
feed)
Milk yield
(kg/day)
Total feed intake
(kg DM/cow per
day)*
Fat content
(%)
Protein content
(%)
Body condition
score
1 0 31.3a – 3.8 3.2 3.1
6 9 108 33.6b – 3.9 3.2 2.9
2 0 36.2 – 3.4 3.2 nd
5 9 108 37.2 – 3.5 3.2 nd
3 0 41.2 23.9 3.7 3.1 3.0
4 9 108 43.0 24.0 3.7 3.0 3.0
4 0 29.2a – 4.0 3.1 2.8
3 9 108 30.1b – 4.1 3.2 2.9
5 0 38.7a 27.5 4.2 3.2 3.0b
2 9 108 42.0b 27.7 4.1 3.3 2.9a
CFU: colony-forming unit; DM: dry matter; nd: not determined.
a,b: Means within a column with different superscript letters are signiﬁcantly different at p < 0.05 in all studies except in study 2
at p < 0.1.
*Estimated on the basis of the average group intake for forage in trials 1 (control: 15.7 kg, Levucell® SC: 16.6 kg), 2 (control:
17.3 kg, Levucell® SC: 18.5 kg) and 4 (control: 27.5 kg, Levucell® SC: 27.8 kg).
44 Technical dossiers/Supplementary information March 2017/Annex 2i.
45 Technical dossiers/Supplementary information March 2017/Annex 2j.
46 Technical dossier FAD-2013-0054/Section IV/Annexes IV_1_7a-c.
47 Technical dossier FAD-2010-0120/Section IV/Annex IV_2_1.
48 Technical dossiers/Supplementary information October 2016/Annexes 9.
49 Technical dossier FAD-2010-0120/Section IV/Annex IV_2_3.
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replications (a single group for each treatment), and the other one50 was discarded due to insufﬁcient
duration (149 days) and unclear description of experimental units (group feeding).
All the studies involved a comparison between a control group (no additive) and a group given a
target dose of Levucell of 7–8 9 108 CFU/head per day (Table 3). Based on the analysed counts in
feed or the premixture to which Levucell was added and the total feed intake, the equivalent dietary
concentration in CFU/kg feed was calculated. In study 1, the additive was Levucell® SC10 ME, in study
2 it was Levucell® SC20, and in studies 3 and 4 Levucell® SC Titan was used. The FEEDAP
Panel considers that the results of efﬁcacy studies can be applied to any of the three available
formulations when used to deliver the same dose.
In the ﬁrst study, Charolais bull calves were stratiﬁed according to day of arrival and initial weight
before being randomly allocated to pens.51 Treatments (control or Levucell® SC) were randomly
allocated to pens (six per treatment). Animals were fed ad libitum a TMR. The additive was mixed with
a protein concentrate and a mineral supplement and then top dressed on the TMR of the treated
group. The concentration of yeast was conﬁrmed in the protein concentrate, and then the
concentration in the feed ingested was calculated to be 5 9 108 CFU/kg complete feed. The treatment
effect on performance was tested using ANOVA. At the beginning of the trial, animals required
intensive veterinary treatments due to adverse climatic conditions and no shelter.
In the second study, pens were then randomly allotted to one of the two groups (control or
Levucell® SC), balanced for the initial BW of the heifers.52 A TMR with whole crop maize as the main
forage ingredient was fed. Levucell® SC was added through a mineral–vitamin premixture, and yeast
cells were determined both in the additive batch and in the premixture. The concentration of yeast in
the feed was calculated to be 6 x 108 CFU/kg complete feed. Data were subjected to one-way ANOVA
to test differences between treatments.
In the third study, individual feed intake was recorded using speciﬁc feeders and distinctive
identiﬁcation transponders.53 The diet was a pelleted feed with concentrates mixed with straw and
middlings as ﬁbre sources. Levucell® SC was added through a middlings premixture. Yeast
concentration was measured in the premixture (7 9 1011 CFU/kg) and in the feed (5 9 108 CFU/kg
complete feed). Data were subjected to ANOVA, using initial BW as covariate and considering each
animal as the experimental unit.
Table 3: Details on the study design for the trials performed in cattle for fattening
Study
Breed
(sex)
Total animals
pen/treatment
3
animals/pen
Levucell® SC
CFU/head
per day
Duration of
the study
(days)
Basal diets
(main ingredients)
1 Charolais
♂
96
6 9 8
Levucell® SC10 ME
8 9 109
262 Maize silage, dried sugar beet pulp,
wheat, straw, soya bean meal
2 Simmental
♀
1971
6 9 16/17
Levucell® SC20
7 9 109
189 Whole crop maize, sunﬂower meal,
soybean meal, alfalfa hay, high
moisture shelled maize
3 Angus
♂
392
19/20 9 1
Levucell® SC Titan
8 9 109
193 Pelleted concentrate with maize
meal, corn DDG’s, wheat middling,
soybean, wheat, palm oil and meal
4 Charolais
♂
1713
6 9 14/15
Levucell® SC Titan
7 9 109
185
(179–189)
Maize silage, high moisture ear
maize, maize meal, maize gluten feed,
dried sugar beet pulp, wheat straw,
concentrate
CFU: colony forming unit.
1: 96 in the control and 101 in the Levucell® SC group.
2: 19 in the control and 20 in the Levucell® SC group.
3: 85 in the control and 86 in the Levucell® SC group.
50 Technical dossier FAD-2010-0120/Section IV/Annex IV_2_2.
51 Technical dossier FAD-2010-0120/Section IV/Annex IV_2_4.
52 Technical dossiers/Supplementary information October 2016/Annexes 10.
53 Technical dossiers/Supplementary information October 2016/Annexes 11.
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At the start of the fourth study, animals were weighed and randomly allocated in pens and these
were randomly assigned to one of the two experimental groups (control or Levucell® SC) balanced for
the initial BW.54 Animals were fed a TMR with maize silage as the main forage ingredient, and
Levucell® SC was added through a protein–mineral–vitamin premix, in which the yeast count was
conﬁrmed by analysis. From this value, it was calculated that the concentration of yeast in complete
feed was 5 9 108 CFU/kg. Data were subjected to one-way ANOVA to test the differences between
experimental treatments.
In three of the studies, a TMR with maize silage was the main forage ingredient and different
concentrates were used to feed the animals (studies 1, 2 and 4). In these studies, feed intake was
monitored by pen, and this was taken as the experimental unit. In study 3, a pelleted feed with
concentrate, straw and middlings was used. In this latter study, animals were individually fed, and
each animal was considered as the experimental unit. In all the studies growth performance was
assessed by recording feed intake (per pen in studies 1, 2 and 4; or individual feed intake in study 3),
initial and ﬁnal body weight (BW) (with intermediate recordings in some studies). From these
parameters, average daily gain (ADG) and feed to gain ratio were calculated. In studies 1, 2 and 4,
carcass quality traits (weight, grading, dressing percentage) were monitored at the slaughter house.
The results of the four studies are summarised in Table 4.
In study 2, the addition of Levucell® SC increased ADG signiﬁcantly, with no effects on the other
performance parameters. In study 3, there were no signiﬁcant differences between groups in ﬁnal BW
and ADG, but feed to gain ratio was signiﬁcantly improved in the Levucell® SC group compared with
the control group. Effects of the additive on growth performance did not reach statistical signiﬁcance
in studies 1 and 4. But in study 4, animals were slaughtered at a similar ﬁnal weight, and it was
observed that steers of the Levucell® SC group reached the ﬁnal weight with signiﬁcant less days on
fattening than the control animals (179 vs 189 days, p = 0.08, respectively).
Therefore, Levucell® SC at 8 9 109 CFU/head and day has the potential to improve the growth
performance of cattle for fattening. This would approximate to a dose of 6 9 108 CFU/kg complete
feedingstuffs.
3.3.4. Efﬁcacy for minor ruminant species and camelids reared for fattening
Efﬁcacy has been demonstrated for the major species (cattle for fattening). Given the physiological
similarity (in gastrointestinal function and metabolism) between major and minor ruminant species, it
can be reasonably assumed that the mechanism of action of the additive to be same. Therefore, data
can be extrapolated between animals which are kept for the same purpose (in this case for fattening)
at the dose of 6 9 108 CFU/kg complete feedingstuffs, without the need for species speciﬁc studies.
The applicant also proposes the use of the additive in growing camelids. There are anatomical
differences in the gastrointestinal tract compared with ruminants, as camelids only have two pre-gastric
Table 4: Effect of Levucell® SC on performance of cattle for fattening
Study
Levucell® SC
(CFU/kg
feed)
Initial weight
(kg)
Final body
weight
(kg)
Average daily
gain (kg)
Daily feed intake
(kg DM/day)*
Feed:gain
1 0 334 653 1.52 8.6 5.75
5 9 108 336 665 1.56 8.6 5.54
2 0 288 477 1.03a 7.0 6.80
6 9 108 317 525 1.13b 7.3 6.56
3 0 177 479 1.57 7.8b 5.01b
5 9 108 176 489 1.62 7.5a 4.63a
4 0 442 744** 1.60 10.4 6.48
5 9 108 441 741** 1.68 11.0 6.60
CFU: colony forming unit.
*: In study 3, intake is for complete feed (as fed, 88% DM)
**: Animals were slaughtered at a pre-determined weight reached at 189 days for the control and 179 days for the Levucell® SC
(p < 0.10)
a,b: Means within a column with different superscript letters are signiﬁcantly different at p < 0.1
54 Technical dossiers/Supplementary information October 2016/Annexes 12.
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chambers (Reece et al., 2015). However, the strategy for digestion is essentially the same in camelids and
ruminants, as in both there is a foregut pregastric microbial fermentation of feed (Fowler and Bravo,
2010; Reece et al., 2015). Therefore, the FEEDAP Panel accepts that data can be extrapolated to
camelids kept for the same purpose (in this case for fattening) at the dose of 6 9 108 CFU/kg complete
feedingstuffs, without the need for species speciﬁc studies.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation55 and Good
Manufacturing Practice.
4. Conclusions
The FEEDAP Panel considers that the three available Levucell SC formulations are equivalent when
used to deliver the same dose.
The active agent fulﬁls the requirements of the QPS approach to the assessment of safety and no
concerns are expected from other components of the additive. Consequently, Levucell SC can be
presumed safe for the target animals, consumers of products from treated animals and the
environment.
Levucell SC is not a skin irritant or sensitiser but is an eye irritant. Inhalation exposure is unlikely.
Encapsulation is not expected to introduce hazards for users.
The FEEDAP Panel cannot conclude on the efﬁcacy of Levucell SC for dairy cows due to an
insufﬁcient number of positive studies. Consequently, no conclusion on minor dairy ruminant species or
dairy camelids can be drawn.
Levucell SC has a potential to improve the performance of cattle raised for fattening when supplied at
a minimum dose of 6 x 108 CFU/kg complete feed. This conclusion is extended to minor ruminant species
and camelids reared for meat production at the same minimum concentration of 6 9 108 CFU/kg
complete feed.
Documentation provided to EFSA
1) Saccharomyces cerevisiae CNCM I-1077 Levucell® SC. Application for the re-registration (under
article 10 of Regulation (EC) No 1831/2003) of the use of Levucell SC 20, 10 ME and/or Titan in
Beef Cattle and Dairy Cows. September 2010. Submitted by Lallemand S.A.S.
2) Saccharomyces cerevisiae CNCM I-1077. Application for the extension of use of Levucell SC
20/10 (ME) Titan to Calves, Buffaloes, and All (including Pseudo-) Ruminant species.
November 2013. Submitted by Lallemand S.A.S.
3) Application for authorisation of Levucell SC20 and Levucell SC10 ME/Titan (Saccharomyces
cerevisiae CNCM I-1077) for dairy cows and cattle for fattening and for minor ruminant species
and camels submitted under Articles 10(2) and 4(1) of Regulation (EC) No 1831/2003.
Supplementary Information. October 2016. Submitted by Lallemand S.A.S.
4) Application for authorisation of Levucell SC20 and Levucell SC10 ME/Titan (Saccharomyces
cerevisiae CNCM I-1077) for dairy cows and cattle for fattening and for minor ruminant species
and camels submitted under Articles 10(2) and 4(1) of Regulation (EC) No 1831/2003.
Supplementary Information. March 2017. Submitted by Lallemand S.A.S.
5) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Levucell SC.
6) Comments from Member States.
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ANOVA analysis of variance
ADG average daily gain
BCS body condition score
BW body weight
CFU colony-forming unit
CNCM Collection Nationale de Cultures de Microorganismes
CV coefﬁcient of variation
DM dry matter
EURL European Union Reference Laboratory
LOQ limit of quantiﬁcation
PCR polymerase chain reaction
QPS Qualiﬁed Presumption of Safety
RH relative humidity
SCAN Scientiﬁc Committee on Animal Nutrition
TMR Total Mixed Ration
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Appendix A – Executive Summary of the Evaluation Report of the
Community Reference Laboratory for Feed Additives on the Methods of
Analysis for Levucell SC
In the current application authorisation is sought under article 10(2) for Saccharomyces cerevisiae
CNCM I-1077 under the category / functional group 4(a) ‘zootechnical additives’/‘digestability
enhancers’ and ‘gut ﬂora stabilisers’, according to Annex I of Regulation (EC) No 1831/2003.
The feed additive is intended to be marketed as a powder (Levucell SC 20) or in micro-encapsulated
form (Levucell SC 10 ME and Levucell SC 10 ME Titan). The active substance of the feed additive are
viable cells of Saccharomyces cerevisiae CNCM I-1077 at a minimum concentration of 1 9 109 CFU/g
product. The strain is deposited at Collection Nationale de Cultures de Micro-organismes (C.N.C.M.) at
Pasteur Institute.
The feed additive is intended to be used in feedingstuffs through premixtures. Speciﬁcally, the
authorisation is sought for the use of the feed additive for dairy cows and beef cattle at a minimum
dose of 4 9 108 and 5 9 108 CFU / kg feedingstuffs, respectively.
For the identiﬁcation of Saccharomyces cerevisiae CNCM I-1077 the Applicant submitted the
polymerase chain reaction (PCR) ampliﬁcation method, a generally recognised methodology for
microbial identiﬁcation. This method was ring-trial validated to become the CEN technical standard
(CEN/TS 15790:2008). The latter is recommended by EURL for ofﬁcial control to identify the
Saccharomyces cerevisiae CNCM I-1077.
For the enumeration of Saccharomyces cerevisiae CNCM I-10077 in feed additive, premixtures and
feedingstuffs the Applicant submitted the ring-trial validated CEN pour plate method for the
enumeration of yeast probiotic strains (EN 15789), using yeast extract dextrose chloramphenicol agar
(CGYE). The performance characteristics of the EN 15789 method reported after logarithmic
transformation (CFU) are:
• a repeatability standard deviation (sr) ranging from 0.17 to 0.36 log10 CFU/g;
• a reproducibility standard deviation (sR) ranging from 0.55 to 0.60 log10 CFU/g; and
• a limit of quantiﬁcation (LOQ) of 1 9 105 CFU/kg, well below the minimum dose proposed by
the Applicant.
Based on these performance characteristics the EURL recommends for ofﬁcial control, the CEN
method EN 15789 for the enumeration of Saccharomyces cerevisiae CNCM I-1077 in feed additive,
premixtures and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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